mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-06 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-06 |
mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-06 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
3e-06 |
mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
0.21 |
3e-06 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
3e-06 |
mRNA |
Vorinostat |
gCSI |
pan-cancer |
AAC |
0.24 |
3e-06 |
mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
4e-06 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
4e-06 |